그리폴스(ADR)(GRFS)는 NAS에 상장된 Healthcare · Drug Manufacturers - General 기업입니다. 현재가 $7.31 (-1.22%), 시가총액 $5.28B, PER 10.78.
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services.
그리폴스(ADR)의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
그리폴스(ADR)의 현재 주가는 $7.31 (-1.22%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
그리폴스(ADR)의 시가총액은 약 $5.28B입니다. PER은 10.78입니다.
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and…